Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 13/20 | 0.43 |
| ▸ | CRBN | Q96SW2 | 13/20 | 0.43 |
| ▸ | IKZF2 | Q9UKS7 | 4/20 | 0.43 |
| ▸ | IKZF3 | Q9UKT9 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | IKZF1 | Q13422 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24315750 | 0.92 | IKZF2 (0.46) | DDB1CRBNIKZF2IKZF3ALDH1A1 | |
| SCHEMBL26664956 | 0.91 | IKZF2 (0.44) | DDB1CRBNIKZF2IKZF3ALDH1A1 | |
| SCHEMBL26664951 | 0.90 | IKZF2 (0.43) | DDB1CRBNIKZF2IKZF3ALDH1A1 | |
| SCHEMBL24315676 | 0.90 | IKZF2 (0.43) | DDB1CRBNIKZF2IKZF3ALDH1A1 | |
| SCHEMBL24315980 | 0.87 | CRBN (0.45) | DDB1CRBNIKZF3ALDH1A1CHRM2 | |
| SCHEMBL26648211 | 0.85 | IKZF2 (0.46) | DDB1CRBNIKZF2IKZF3ALDH1A1 | |
| SCHEMBL24315922 | 0.85 | IKZF2 (0.46) | DDB1CRBNIKZF2IKZF3ALDH1A1 | |
| SCHEMBL24315891 | 0.83 | IKZF2 (0.48) | DDB1CRBNIKZF2IKZF3ALDH1A1 | |
| SCHEMBL24315840 | 0.83 | IKZF2 (0.44) | DDB1CRBNIKZF2IKZF3ALDH1A1 | |
| SCHEMBL24315760 | 0.83 | CRBN (0.51) | DDB1CRBNIKZF2IKZF3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022081925-A1 | TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 | C4 THERAPEUTICS, INC. (US) | 2022-04-21 | — | — | WO | disclosed |
| US-9585884-B2 | Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2017-03-07 | — | — | US | disclosed |